Results 221 to 230 of about 4,801,388 (251)

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Causal assessment of 187 dietary habits with ovarian cancer from multiple sources via Mendelian randomization and meta-analysis. [PDF]

Medicine (Baltimore)
Yu C, Ruoxi Z, Xu J, Ye Z.
europepmc   +1 more source

Liquid biopsy across cancers: Integrating circulating biomarkers, tumor biology, artificial intelligence, and clinical translation

Interdisciplinary Medicine, EarlyView.
Liquid biopsy uses non‐invasive sampling of blood or body fluids to isolate circulating analytes, including circulating tumor DNA, circulating tumor cells, extracellular vesicles, and RNA. These are analyzed using next‐generation sequencing, qPCR, and proteomics to inform cancer detection, monitoring, and characterization. Figure created with BioRender.
Jaswinder Singh, Manjeet Kumar, Kajal Kamra   +2 more
wiley   +1 more source

Ovarian cancer in Asia: incidence, mortality in 2022, and future projections to 2050. [PDF]

BMC Public Health
Fu Y, Xu Y, Zhang B, Fu M, Sun H.
europepmc   +1 more source

A Multistate Survival Model to Identify Risk Factors for Lethal Ovarian Cancer. [PDF]

Cancer Epidemiol Biomarkers Prev
Townsend MK, Eliassen AH, Terry KL, Tworoger SS, Rosner B.   +4 more
europepmc   +1 more source

Prognostic and therapeutic implications of BRCA1 and BRCA2 mutations in ovarian cancer. [PDF]

Front Oncol
Pawul W, Opoka P, Dusza A, Blajerski B, Orzelska J, Gierulska N, Kułak K, Tarkowski R.   +7 more
europepmc   +1 more source

Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant. [PDF]

Breast Cancer
Nahshon C, Fahoum L, Hadar D, Cohen H, Michaelson-Cohen R, Regev S, Schmidt M, Assaf W, Narod SA, Segev Y.   +9 more
europepmc   +1 more source

Trends and disparities in ovarian cancer incidence and mortality in the United States, 1999 to 2023: A population-based ecological trend analysis. [PDF]

Medicine (Baltimore)
Huang S, Mo Q.
europepmc   +1 more source